SCHEMBL19686169

SCHEMBL19686169

Cc1ccc2c(c1)C1(c3ccccc3-c3ccccc31)c1cc(C)ccc1N2c1ccc2c(c1)c(=O)c(C)cn2-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN2B O60939 2/20 0.34
SCN1A P35498 2/20 0.34
SCN1B Q07699 2/20 0.34
SCN9A Q15858 2/20 0.34
SCN5A Q14524 1/20 0.34
PGR P06401 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
BLM P54132 1/20 0.32
PLA2G4A P47712 1/20 0.32
KMT2A Q03164 3/20 0.32
LMNA P02545 1/20 0.32
FGFR1 P11362 1/20 0.32
PKM P14618 1/20 0.31
CNR1 P21554 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19686033 0.92 PGR (0.32) SCN2BSCN1ASCN1BSCN9ASCN5A
SCHEMBL19685873 0.92 SCN2B (0.36) SCN2BSCN1ASCN1BSCN9ASCN5A
SCHEMBL19685976 0.89 SCN2B (0.32) SCN2BSCN1ASCN1BSCN9ASCN5A
SCHEMBL19685817 0.88 TP53 (0.35) PGRKDM4EALDH1A1KMT2ALMNA
SCHEMBL19685984 0.85 ESR1 (0.33) PGRKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL19685927 0.85 ESR1 (0.35) PGRKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL19686035 0.83 MEN1 (0.33) SCN2BSCN1ASCN1BSCN9ASCN5A
SCHEMBL19685977 0.83 SCN2B (0.34) SCN2BSCN1ASCN1BSCN9ASCN5A
SCHEMBL19685869 0.82 SCN2B (0.36) SCN2BSCN1ASCN1BSCN9ASCN5A
SCHEMBL19685862 0.82 TP53 (0.35) PGRALDH1A1KMT2APKMCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS SCN2B 3140/4885SCN1A 1889/4885SCN1B 1563/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS SCN2B 3140/4885SCN1A 1889/4885SCN1B 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.